跳至主要内容
临床试验/NCT01722708
NCT01722708已完成不适用

Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies

HaEmek Medical Center, Israel2 个研究点 分布在 1 个国家目标入组 166 人开始时间: 2012年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
166
试验地点
2
主要终点
To compare the efficacy between oral Clindamycin Vs Metronidazole in the eradication of abnormal vaginal flora

研究概览

简要总结

Abnormal vaginal flora is a risk factor for preterm labor. Therefore, in high risk pregnancies for preterm labor the diagnosis and treatment of abnormal flora is indicated. Clindamycin and metronidazole given orally are both acceptable treatments in these cases. The purpose of this study is to compare the effectiveness of Clindamycin Vs metronidazole for the treatment of abnormal vaginal flora in high risk pregnancies. For this purpose, pregnant women who are considered high risk for preterm labor and were diagnosed with abnormal vaginal flora will be randomly treated either with clindamycin or metronidazole. Eradication of the abnormal flora and adverse effects will be monitored and compared

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women at increased risk for preterm labor (preterm cervical effacement, preterm uterine contractions, twins pregnancy, vaginal bleeding, past preterm delivery)
  • Age above 18 years

排除标准

  • Known allergy to the tested antibiotics
  • Antibacterial treatment in the week before the vaginal culture was taken
  • preterm premature rupture of membranes

研究组 & 干预措施

clindamycin

Experimental

干预措施: Clindamycin (Drug)

metronidazole

Experimental

干预措施: Metronidazole (Drug)

结局指标

主要结局

To compare the efficacy between oral Clindamycin Vs Metronidazole in the eradication of abnormal vaginal flora

时间窗: Primary outcome will be assessed by taking a vaginal culture sample a week after one-week antibacterial treatment

次要结局

  • The prevalence of late abortions and preterm deliveries(From date of randomization until the date of delivery or abortion, assessed up to 28 weeks)
  • Assessing the correlation between Nugent score , physical examination and Ph indicators(The outcome is assessed after the diagnosis of abnormal vaginal flora is made at 14-26 weeks of gestation)
  • The prevalence of adverse effects(During the antibacterial treatment which is 1 week of therapy)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验